Role of imprint cytology in the intraoperative evaluation of sentinel lymph nodes for malignant melanoma

European Journal of Cancer

Volumn 39, Issue 15, 2003, Pages 2173-2178

  Hocevat M ^a   Bracko, M ^a   Pogacnik, A ^a   Vidergar Kralj, B ^a   Besic, N ^a   Zgajnar, J ^a  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

Imprint cytology; Malignant melanoma; Metastases; Sentinel lymph node

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; CYTOLOGY; EVALUATION; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAOPERATIVE PERIOD; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; PREDICTION; PRIORITY JOURNAL; SENTINEL LYMPH NODE; SURGICAL TECHNIQUE; TISSUE SECTION;

EID: 0142027973     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(03)00453-2     Document Type: Article

References (25)

1. Rigel D.S., Friedman R.J., Kopf A.W. The incidence of malignant melanoma in the United States. issues as we approach the 21st century J. Am. Acad. Dermatol. 34:1996;839-847.
2. Balch C.M., Soong S.J., Milton G.W.et al. A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia. Ann. Surg. 196:1982;677-684.
3. Kim S.H., Garcia C., Rodriguez J., Coit D.G. Prognosis of thick cutaneous melanoma. J. Am. Coll. Surg. 188:1999;241-247.
4. Morton D.L., Wen D.R., Wong J.H.et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch. Surg. 127:1992;392-399.
5. Ferrone C.R., Panageas K.S., Busam K., Brady M.S., Coit D.G. Multivariate prognostic model for patients with thick cutaneous melanoma. importance of sentinel lymph node status Ann. Surg. Oncol. 9:2002;637-645.
6. Gershenwald J.E., Thompson W., Mansfield P.F.et al. Multi-institutional melanoma lymphatic mapping experience. the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients J. Clin. Oncol. 17:1999;976-983.
7. Gershenwald J.E., Mansfield P.F., Lee J.E., Ross M.I. Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (> or=4 mm) primary melanoma. Ann. Surg. Oncol. 7:2000;160-165.
8. Cochran A.J. Surgical pathology remains pivotal in the evaluation of 'sentinel' lymph nodes. Am. J. Surg. Pathol. 23:1999;1169-1172.
9. Ratanawichitrasin A., Biscotti C.V., Levy L., Crowe J.P. Touch imprint cytological analysis of sentinel lymph nodes for detecting axillary metastases in patients with breast cancer. Br. J. Surg. 86:1999;1346-1348.
10. Cserni G. The potential value of intraoperative imprint cytology of axillary sentinel lymph nodes in breast cancer patients. Am. Surg. 67:2001;86-91.
11. Teng S., Dupont E., McCann C.et al. Do cytokeratin-positive-only sentinel lymph nodes warrant complete axillary lymph node dissection in patients with invasive breast cancer? Am. Surg. 66:2000;574-578.
12. Creager A.J., Shiver S.A., Shen P., Geisinger K.R., Levine E.A. Intraoperative evaluation of sentinel lymph nodes for metastatic melanoma by imprint cytology. Cancer. 94:2002;3016-3022.
13. McMasters K.M., Wong S.L., Edwards M.J.et al. Frequency of nonsentinel lymph node metastasis in melanoma. Ann. Surg. Oncol. 9:2002;137-141.
14. Van Diest P.J., Torrenga H., Borgstein P.J.et al. Reliability of intraoperative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer. Histopathology. 35:1999;14-18.
15. Zurrida S., Galimberti V., Orvieto E.et al. Radioguided sentinel node biopsy to avoid axillary dissection in breast cancer. Ann. Surg. Oncol. 7:2000;28-31.
16. Gibbs J.F., Huang P.P., Zhang P.J., Kraybill W.G., Cheney R. Accuracy of pathologic techniques for the diagnosis of metastatic melanoma in sentinel lymph nodes. Ann. Surg. Oncol. 6:1999;699-704.
17. Koopal S.A., Tiebosch A.T., Albertus P.D., Plukker J.T., Schraffordt K.H., Hoekstra H.J. Frozen section analysis of sentinel lymph nodes in melanoma patients. Cancer. 89:2000;1720-1725.
18. Messina J.L., Glass L.F., Cruse C.W., Berman C., Ku N.K., Reintgen D.S. Pathologic examination of the sentinel lymph node in malignant melanoma. Am. J. Surg. Pathol. 23:1999;686-690.
19. Stojadinovic A., Allen P.J., Clary B.M., Busam K.J., Coit D.G. Value of frozen-section analysis of sentinel lymph nodes for primary cutaneous malignant melanoma. Ann. Surg. 235:2002;92-98.
20. Cserni G. Metastases in axillary sentinel lymph nodes in breast cancer as detected by intensive histopathological work up. J. Clin. Pathol. 52:1999;922-924.
21. Hill A.D., Tran K.N., Akhurst T.et al. Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann. Surg. 229:1999;528-535.
22. Pendas S., Dauway E., Cox C.E.et al. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients. Am. Surg. 65:1999;500-505.
23. Turner R.R., Hansen N.M., Stern S.L., Giuliano A.E. Intraoperative examination of the sentinel lymph node for breast carcinoma staging. Am. J. Clin. Pathol. 112:1999;627-634.
24. Doting M., Hoekstra H., Plukker J.et al. Is sentinel node biopsy beneficial in melanoma patients? A report on 200 patients with cutaneous melanoma. Eur. J. Surg. Oncol. 28:2002;673.
25. McMasters K.M., Chao C., Wong S.L.et al. Interval sentinel lymph nodes in melanoma. Arch. Surg. 137:2002;543-547.